Novo Holdings Leads US$21M Series A Financing in BIOMILQ
Funds will be used to support the development of pioneering mammary biotechnology to bring a novel infant feeding option to market that better meets infants' nutritional needs
21-Oct-2021 -
Novo Holdings, a leading international life science investor, today announces it has led the US$21 million Series A financing in BIOMILQ, Inc. ("BIOMILQ"), a first-of-its-kind mammary biotechnology company.
BIOMILQ is developing a novel infant feeding option, derived from human mammary cells, to ...
biotechnology
breast milk
infant nutrition
+1